Home » Market News » DirectorsTalk Highlights » Avacta Group appoints Stifel Nicolaus Europe as joint broker
Avacta Group Plc

Avacta Group appoints Stifel Nicolaus Europe as joint broker

Avacta Group plc (LON:AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISIONTM platforms, has announced the appointment of Stifel Nicolaus Europe Limited as joint broker with immediate effect.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.